Development of the Japanese version of the Challenging Experience Questionnaire
Hideaki Tani, Kengo Yonezawa, Keisuke Kusudo, Frederick S. Barrett, Shinichiro Nakajima, Hiroyuki Uchida
Neuropsychopharmacology Reports November 8, 2024 DOI: 10.1002/npr2.12456 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Translation and cultural adaptation study Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Challenging experience questionnaire Psychedelics Psychedelic therapy research Cross-cultural adaptation Human research Clinical application Therapeutic use Human experiences Instrument Assessment Evaluation Difficult experiences Challenging aspects Japanese version Back-translation Cultural relevance |
| Citations | 1 |
| Key points | A Japanese version of the Challenging Experience Questionnaire was developed and approved by the original authors through forward and back translation with cultural adaptation. |
Abstract
Abstract Introduction The therapeutic potential of psychedelics for various mental disorders has gained significant interest. Previous studies have highlighted that psychedelics induce psychoactive effects, including challenging aspects of experiences. These experiences are assessed using the Challenging Experience Questionnaire (CEQ), yet its Japanese version has been unavailable. This study aimed to create a Japanese version of the CEQ.
Methods: We followed the “Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient‐Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation.” Initially, two Japanese psychiatrists independently conducted the forward translations. These were then reconciled into a single version, which was back‐translated into English. The original authors reviewed this back‐translation for accuracy, leading to revisions through continuous dialogue until the original authors approved the final version.
Results: The final, approved back‐translated version of the CEQ is presented in the figure.
Conclusions: This study developed a Japanese version of the CEQ, enabling the assessment of challenging experiences during psychedelic‐assisted therapy for Japanese speakers. Further studies are needed to assess the reliability and validity of this newly translated version.
Citations in the library
Cited by 2
- Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire Neuropsychopharmacology Reports August 27, 2026
- Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review Frontiers in Psychiatry August 6, 2026
Cites 24
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 19 more in the library